(2-(methoxy-d3)-6-(trifluoromethyl)pyridin-4-yl)boronic acid
95%
- Product Code: 56335
CAS:
2241875-96-5
| Molecular Weight: | 223.960074934 g./mol | Molecular Formula: | C₇H₄BD₃F₃NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃, sealed and dry |
Product Description:
This compound is primarily used in the pharmaceutical and agrochemical industries as a key intermediate in the synthesis of more complex molecules. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to form carbon-carbon bonds in the production of drugs and other bioactive compounds. The trifluoromethyl group enhances the lipophilicity and metabolic stability of the resulting molecules, making it particularly useful in designing compounds with improved pharmacokinetic properties. Additionally, the deuterated methoxy group can be leveraged in studies involving isotopic labeling, aiding in drug metabolism research and the development of deuterated drugs for enhanced efficacy and safety.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $2,582.66 |
+
-
|
| 0.025 | 10-20 days | $6,714.67 |
+
-
|
(2-(methoxy-d3)-6-(trifluoromethyl)pyridin-4-yl)boronic acid
This compound is primarily used in the pharmaceutical and agrochemical industries as a key intermediate in the synthesis of more complex molecules. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to form carbon-carbon bonds in the production of drugs and other bioactive compounds. The trifluoromethyl group enhances the lipophilicity and metabolic stability of the resulting molecules, making it particularly useful in designing compounds with improved pharmacokinetic properties. Additionally, the deuterated methoxy group can be leveraged in studies involving isotopic labeling, aiding in drug metabolism research and the development of deuterated drugs for enhanced efficacy and safety.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :